Use of a glycolipid inhibitor to ameliorate renal cancer in a mouse model.
In a xenograft model wherein, live renal cancer cells were implanted under the kidney capsule in mice, revealed a 30-fold increase in tumor volume over a period of 26 days and this was accompanied with a 32-fold increase in the level of lactosylceramide (LacCer). Mice fed D- threo-1-phenyl-2-decanoy...
| Main Authors: | , , , , , , , , |
|---|---|
| 格式: | Article |
| 語言: | English |
| 出版: |
Public Library of Science (PLoS)
2013-01-01
|
| 叢編: | PLoS ONE |
| 在線閱讀: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23671696/?tool=EBI |